Sonus Pharmaceuticals

SONUS PHARMACEUTICALS is focused on the development of drugs that provide better therapeutic alternatives for cancer patients,including improved efficacy,safety and tolerability,and are more convenient to use

Contact Details: 22026 20th Avenue SE Bothell Washington 98021 United States of America Tel: 425.487.9500 Fax: 425.489.0626 Email: info@sonuspharma.com WWW: www.sonuspharma.com/

Loading...

Recent Publications by Sonus Pharmaceuticals:
The use of hepatocytes in evaluating time-dependent inactivation of P450 in vivo. BACKGROUND: Time-dependent inactivation (TDI) of P450 is an important...	23rd April, 2008	Sonus Pharmaceuticals,	Expert Opin Drug Metab Toxicol. 2008 Feb;4(2):151-64.
Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel. PURPOSE: Paclitaxel is currently administered i.v. as a slow infusion of a...	10th June, 2000	SONUS Pharmaceuticals, Bothell, Washington 98021, USA.	Pharm Res. 2000 Feb;17(2):175-82.

Press Releases on Sonus Pharmaceuticals:
OncoGenex Reports Third Quarter 2009 Financial Results	5th November, 2009	OncoGenex Pharmaceuticals, Inc.	Conference Call on Thursday, November 5, 2009 at 4:30 p.m. Eastern Time BOTHELL, WA and VANCOUVER Nov. 5 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or the "
OncoGenex Reports Second Quarter 2009 Financial Results	6th August, 2009	OncoGenex Pharmaceuticals, Inc.	Conference Call on Thursday, August 6, 2009 at 4:30 p.m. Eastern Time BOTHELL, WA, and VANCOUVER, Aug. 6 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or the
OncoGenex Reports First Quarter Financial Results	7th May, 2009	OncoGenex Pharmaceuticals, Inc.	Conference Call on Thursday, May 7, 2009 at 4:30 p.m. Eastern Time BOTHELL, WA, and VANCOUVER, May 7 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or the "
OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009	11th March, 2009	OncoGenex Pharmaceuticals, Inc.	Conference Call on Wednesday, March 11, 2009 at 4:30 p.m. Eastern Time BOTHELL, WA, and VANCOUVER, March 11 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or the
OGX-011 Shows Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study	3rd December, 2008	OncoGenex Pharmaceuticals, Inc.	First-line trial currently shows median overall survival of 27.5 months for OGX-011 in combination with docetaxel and prednisone and a 16.9 months overall survival for docetaxel and

BioNews Results for Sonus Pharmaceuticals:
OncoGenex Reports Third Quarter 2009 Financial Results	SmartBrief:  Nov 6 2009 2:36AM Matching: sonus pharmaceuticals
OncoGenex Reports Third Quarter 2009 Financial Results	KSLA:  Nov 6 2009 3:40AM Matching: sonus pharmaceuticals
OncoGenex Reports Third Quarter 2009 Financial Results	NewsBlaze:  Nov 5 2009 9:41PM Matching: sonus pharmaceuticals
OncoGenex (OGXI): Targeting cancer treatment	TheStockAdvisors.com:  Oct 30 2009 10:50PM Matching: sonus pharmaceuticals
OncoGenex (OGXI): Targeting Cancer Treatment	I Stock Analyst:  Oct 30 2009 4:39PM Matching: sonus pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution	→View more Sonus Pharmaceuticals news.

Sonus Pharmaceuticals Patents:
US Patent No.	Title
7268245	Multinuclear platinum compounds
6245319	Colloidal dispersions of perfluoropentane
6156292	Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media
5897851	Nucleation and activation of a liquid-in-liquid emulsion for use in ultrasound imaging
5876696	Composition comprising a fluorine containing surfactant and perfluoropentane for ultrasound
→View more Sonus Pharmaceuticals patents.

Sonus Pharmaceuticals (SNUS) Financial information Links from Barchart
SNUS Quote from from Barchart.com
SNUS Chart from from Barchart.com
SNUS Profile from from Barchart.com
SNUS Opinion from from Barchart.com
→View more Sonus Pharmaceuticals finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 286 times since April 2007, the link to the organisation's website has been followed 46 times

Search for more companies in Bothell

Search for more companies in Washington

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Sonus Pharmaceuticals